Actively Recruiting
Psychiatric Multi-omics and Neuroimaging Project
Led by mingjun Zhong · Updated on 2026-03-13
1899
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.
CONDITIONS
Official Title
Psychiatric Multi-omics and Neuroimaging Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 13 and 35 years old (patients with healthy siblings may be 14 to 35 years old)
- Disease duration less than 24 months
- Priority given to patients who have never taken medication or have used medication for less than 2 weeks
- No contraindications to magnetic resonance imaging (MRI)
You will not qualify if you...
- Family history of psychotic disorders
- History of psychoactive substance abuse, alcohol dependence, or nicotine dependence
- Major physical disease or infectious disease
- History of coma or serious neurological disease
- Contraindications to MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Second Xiangya hospital of central south univerity
Changsha, Hunan, China, 410000
Actively Recruiting
Research Team
Y
Yunzhi Pan
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here